Regeneron Pharmaceuticals Inc
NASDAQ: REGN
$1,143.78
-$6.41 (-0.6%)
Real Time Data Delayed 15 Min.
REGN Articles
ThinkstockRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NYSE: SNY) announced last Friday that the U.S. Food and Drug Administration (FDA) approved Praluent (alirocumab) Injection....
Published:
Last Updated:
Wednesday's top analyst upgrades, downgrades and initiations include Apple, Exxon Mobil, LifeLock, Microsoft, PayPal and Chipotle Mexican Grill.
Published:
Tuesday's top analyst upgrades, downgrades and initiations include Alarm.com, Pandora Media, PayPal, SanDisk, SunEdison, Tesla Motors and Advanced Micro Devices.
Published:
A new research report from Cowen focuses on the top biotech stocks to buy before second-quarter earnings are reported.
Published:
Thursday's top analyst upgrades, downgrades and initiations include Apple, Envestnet, Pandora Media, Regeneron Pharmaceuticals, Spectra Energy and Travelers.
Published:
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of July and added some color.
Published:
There are still better ways to spend $666 than buying one share of a nosebleed stock with no dividend and a history of collapse on singular mistakes.
Published:
Monday's top analyst upgrades, downgrades and initiations include Exxon Mobil, Home Depot, Lululemon Athletica, 3M, Vodafone, Mondelez International and Chevron.
Published:
This coming week is likely to be a serious one in the fight against cholesterol. FDA panels are evaluating more than just one drug candidate.
Published:
S&P Capital IQ released a report regarding the performance of companies in terms of earnings and revenue.
Published:
There were some interesting positions of hedge funds in biotech, long and short, from the Goldman Sachs Hedge Fund Trend Monitor.
Published:
24/7 Wall St. has generated four earnings previews that investors will be watching closely in the week ahead.
Published:
A big part of the Nasdaq is biotech, and a new report from Cowen details the stocks that big money managers love and are staying with.
Published:
Tuesday's top analyst upgrades, downgrades and initiations from 24/7 Wall St. include American Express, Freescale Semiconductor, Micron Technology and Nordstrom.
Published:
Here are the five biotech stocks that are loved the most by portfolio managers, according to Cowen analysts.
Published: